Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bluebird Bio (NQ: BLUE ) 0.9231 -0.0522 (-5.35%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bluebird Bio < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > 7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline June 17, 2024 With biotech stocks enjoying a permanently relevant narrative, investors should focus on these compelling opportunities. Via InvestorPlace Is Bluebird Bio Stock a Buy? May 16, 2024 It won't be easy for the company to bounce back. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session May 09, 2024 Via Benzinga Is Bluebird Bio Stock a Buy? April 15, 2024 This small biotech is struggling to fly -- and investors should probably steer clear. Via The Motley Fool Better Buy: Bluebird Bio Vs. Novavax April 13, 2024 Who wins this face-to-face between two beaten-down biotechs? Via The Motley Fool Is This Beaten-Down Stock a Good Acquisition Target? April 11, 2024 This company has proven its innovative abilities, but that's not enough to outperform the market. Via The Motley Fool Peeling Back The Layers: Exploring bluebird bio Through Analyst Insights March 27, 2024 Via Benzinga Peering Into bluebird bio's Recent Short Interest March 22, 2024 Via Benzinga Is Bluebird Bio Stock a Buy Now? March 13, 2024 Are you feeling brave? Via The Motley Fool Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst March 29, 2024 Biotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain. Via The Motley Fool Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why March 28, 2024 The company is working to launch its Vertex-partnered gene-editing drug for sickle cell disease and beta thalassemia. Via Investor's Business Daily 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 26, 2024 Via Benzinga Why Bluebird Bio Stock Flew Higher Than the Market Today March 18, 2024 The company was thrown a financial lifeline. Via The Motley Fool Why Bluebird Bio Stock Dived Into the Red on Tuesday March 05, 2024 The biotech has had a tough time of it over the past few years; a pundit's revised take on the company won't improve that situation. Via The Motley Fool Forecasting The Future: 6 Analyst Projections For bluebird bio March 05, 2024 Via Benzinga (BLUE) - Analyzing bluebird bio's Short Interest February 29, 2024 Via Benzinga Earnings Scheduled For March 26, 2024 March 26, 2024 Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. Via Benzinga Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug February 27, 2024 Both companies are working on treatments for genetic disorders. Via Investor's Business Daily If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today January 27, 2024 The answer hardly inspires confidence. Via The Motley Fool Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 29, 2024 Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Via Benzinga Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule January 17, 2024 FDA approves CRISPR Therapeutics/Vertex's Casgevy a gene-edited cell therapy for transfusion-dependent beta-thalassemia. Vertex's swift launch strategy targets a network of treatment centers across the... Via Benzinga Exposures Product Safety Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 27, 2024 Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. Via Benzinga 2 Red Flags for Bluebird Bio Stock January 10, 2024 The biotech's struggles may continue. Via The Motley Fool Better Risky Investment: Bluebird Bio vs. Shiba Inu January 03, 2024 Few investors dare to tread where the ice is known to be very thin. Via The Motley Fool Should You Invest in Bluebird Bio Right Now? December 26, 2023 After two December share price crashes, there's no evident cure for Bluebird Bio's ills. Via The Motley Fool If You Invested $10,000 in Bluebird Bio In 2021, This Is How Much You Would Have Today December 24, 2023 Can things get better for this struggling stock? Via The Motley Fool 1 Green Flag and 1 Red Flag for Bluebird Bio Stock December 23, 2023 The stock has been in the news lately. Via The Motley Fool 3 Money-Saving Tricks for Investing in Biotech Stocks in 2024 December 22, 2023 Doing a little math and doing a little extra research can make a big difference. Via The Motley Fool Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock? December 22, 2023 The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction. Via The Motley Fool Exposures Product Safety 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 21, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.